Leinco Technologies

Recombinant Human EGF

Product Code:
 
LEI-E108
Product Group:
 
Recombinant Proteins
Host Type:
 
Human
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-E108-1mg1 mg£273.00
Quantity:
LEI-E108-200ug200 ug£273.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Epidermal growth factor (EGF), also known as Urogastrone, is a growth factor that plays an important role in the regulation of cell growth, proliferation and differentiation (1). It is produced by many cell types, in blood and various body fluids, including milk, urine, saliva, seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid (1). EGF acts by binding with high affinity to epidermal growth factor receptor (EGFR) on the cell surface, activating an extensive network of signal transduction pathways that include PI3K/AKT, RAS/ERK and JAK/STAT. It is also a mitogen for fibroblasts, epithelial and endothelial cells, and promotes colony formation of epiderma. EGF has been shown to regulate tumor cell invasion through MMP-2 activation in various tumor cell types (2). Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing (3). Because of its key role in driving the proliferation of cells, EGFR is a target of several anti-cancer drugs currently in development.
NCBI Gene:
1950
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
EGF

References

1. Carpenter, G. et al. (1986) J. Biol. Chem. 265:770 2. Cosen-Binker, LI. et al. (2009) Biochem. Biophys. Res. Commun. 379:445 3. Machowska, A. et al. (2008) Inflammopharmacol. 16:40